Sign in

CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330827593
Phone
737.255.7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 37 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-20 Daniels Eric Joseph Chief Development Officer Grant or award · Restricted Stock Units +20,000 20,000
2026-04-20 Daniels Eric Joseph Chief Development Officer Grant or award · Stock Option (Right to Buy) +20,000 20,000
2026-04-01 Sims Andrew John Hugh MacIntyre Chief Financial Officer Option exercise +38,323 144,784
2026-04-01 Sims Andrew John Hugh MacIntyre Chief Financial Officer Option exercise +29,129 173,913
2026-04-01 Sims Andrew John Hugh MacIntyre Chief Financial Officer Option exercise · Restricted Stock Units −38,323 694,451
2026-04-01 Sims Andrew John Hugh MacIntyre Chief Financial Officer Option exercise · Restricted Stock Units −29,129 665,322
2026-04-01 HEDRICK MARC H Chief Executive Officer Option exercise +159,681 499,468
2026-04-01 HEDRICK MARC H Chief Executive Officer Option exercise −201,632 701,100
2026-04-01 HEDRICK MARC H Chief Executive Officer Option exercise · Restricted Stock Units −159,681 3,856,707
2026-04-01 HEDRICK MARC H Chief Executive Officer Option exercise · Restricted Stock Units −201,632 3,655,075
2026-02-25 Sims Andrew John Hugh MacIntyre Chief Financial Officer Grant or award · Restricted Stock Units +349,542 732,774
2026-02-25 Sims Andrew John Hugh MacIntyre Chief Financial Officer Grant or award · Stock Option (Right to Buy) +349,541 349,541
2026-02-25 HEDRICK MARC H Chief Executive Officer Grant or award · Restricted Stock Units +2,419,582 4,016,388
2026-02-25 HEDRICK MARC H Chief Executive Officer Grant or award · Stock Option (Right to Buy) +2,419,582 2,419,582
2026-01-01 HEDRICK MARC H Chief Executive Officer Option exercise +159,681 339,787
2026-01-01 HEDRICK MARC H Chief Executive Officer Option exercise · Restricted Stock Units −159,681 1,596,806
2026-01-01 Sims Andrew John Hugh MacIntyre Chief Financial Officer Option exercise +38,323 106,461
2026-01-01 Sims Andrew John Hugh MacIntyre Chief Financial Officer Option exercise · Restricted Stock Units −38,323 383,232
2025-11-04 Sims Andrew John Hugh MacIntyre Chief Financial Officer Purchase +20,000 $0.51 $10K 68,138
2025-10-01 HEDRICK MARC H Chief Executive Officer Option exercise +159,681 180,106

Page 4 of 53 · 1,048 trades